Steven R Goldsmith. Cleve Clin J Med 2006
Times Cited: 32
Times Cited: 32
Times Cited
Times Co-cited
Similarity
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.
Marvin A Konstam, Mihai Gheorghiade, John C Burnett, Liliana Grinfeld, Aldo P Maggioni, Karl Swedberg, James E Udelson, Faiez Zannad, Thomas Cook, John Ouyang,[...]. JAMA 2007
Marvin A Konstam, Mihai Gheorghiade, John C Burnett, Liliana Grinfeld, Aldo P Maggioni, Karl Swedberg, James E Udelson, Faiez Zannad, Thomas Cook, John Ouyang,[...]. JAMA 2007
21
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.
Mihai Gheorghiade, Wendy A Gattis, Christopher M O'Connor, Kirkwood F Adams, Uri Elkayam, Alejandro Barbagelata, Jalal K Ghali, Raymond L Benza, Frank A McGrew, Marc Klapholz,[...]. JAMA 2004
Mihai Gheorghiade, Wendy A Gattis, Christopher M O'Connor, Kirkwood F Adams, Uri Elkayam, Alejandro Barbagelata, Jalal K Ghali, Raymond L Benza, Frank A McGrew, Marc Klapholz,[...]. JAMA 2004
21
Vasopressin: a new target for the treatment of heart failure.
Craig R Lee, Michael L Watkins, J Herbert Patterson, Wendy Gattis, Christopher M O'connor, Mihai Gheorghiade, Kirkwood F Adams. Am Heart J 2003
Craig R Lee, Michael L Watkins, J Herbert Patterson, Wendy Gattis, Christopher M O'connor, Mihai Gheorghiade, Kirkwood F Adams. Am Heart J 2003
21
Increased plasma arginine vasopressin levels in patients with congestive heart failure.
S R Goldsmith, G S Francis, A W Cowley, T B Levine, J N Cohn. J Am Coll Cardiol 1983
S R Goldsmith, G S Francis, A W Cowley, T B Levine, J N Cohn. J Am Coll Cardiol 1983
21
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
G S Francis, C Benedict, D E Johnstone, P C Kirlin, J Nicklas, C S Liang, S H Kubo, E Rudin-Toretsky, S Yusuf. Circulation 1990
G S Francis, C Benedict, D E Johnstone, P C Kirlin, J Nicklas, C S Liang, S H Kubo, E Rudin-Toretsky, S Yusuf. Circulation 1990
18
Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin.
P R Kalra, S D Anker, A J Coats. Cardiovasc Res 2001
P R Kalra, S D Anker, A J Coats. Cardiovasc Res 2001
15
The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.
M Packer. J Am Coll Cardiol 1992
M Packer. J Am Coll Cardiol 1992
15
Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients.
William T Abraham, Alireza A Shamshirsaz, Kim McFann, Ron M Oren, Robert W Schrier. J Am Coll Cardiol 2006
William T Abraham, Alireza A Shamshirsaz, Kim McFann, Ron M Oren, Robert W Schrier. J Am Coll Cardiol 2006
15
Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
James E Udelson, Frank A McGrew, Enrique Flores, Hassan Ibrahim, Stewart Katz, Gregory Koshkarian, Terrence O'Brien, Marvin W Kronenberg, Christopher Zimmer, Cesare Orlandi,[...]. J Am Coll Cardiol 2007
James E Udelson, Frank A McGrew, Enrique Flores, Hassan Ibrahim, Stewart Katz, Gregory Koshkarian, Terrence O'Brien, Marvin W Kronenberg, Christopher Zimmer, Cesare Orlandi,[...]. J Am Coll Cardiol 2007
15
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Mihai Gheorghiade, Marvin A Konstam, John C Burnett, Liliana Grinfeld, Aldo P Maggioni, Karl Swedberg, James E Udelson, Faiez Zannad, Thomas Cook, John Ouyang,[...]. JAMA 2007
Mihai Gheorghiade, Marvin A Konstam, John C Burnett, Liliana Grinfeld, Aldo P Maggioni, Karl Swedberg, James E Udelson, Faiez Zannad, Thomas Cook, John Ouyang,[...]. JAMA 2007
15
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.
G J Hasking, M D Esler, G L Jennings, D Burton, J A Johns, P I Korner. Circulation 1986
G J Hasking, M D Esler, G L Jennings, D Burton, J A Johns, P I Korner. Circulation 1986
15
Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure.
J E Udelson, W B Smith, G H Hendrix, C A Painchaud, M Ghazzi, I Thomas, J K Ghali, P Selaru, F Chanoine, M L Pressler,[...]. Circulation 2001
J E Udelson, W B Smith, G H Hendrix, C A Painchaud, M Ghazzi, I Thomas, J K Ghali, P Selaru, F Chanoine, M L Pressler,[...]. Circulation 2001
15
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
Liviu Klein, Christopher M O'Connor, Jeffrey D Leimberger, Wendy Gattis-Stough, Ileana L Piña, G Michael Felker, Kirkwood F Adams, Robert M Califf, Mihai Gheorghiade. Circulation 2005
Liviu Klein, Christopher M O'Connor, Jeffrey D Leimberger, Wendy Gattis-Stough, Ileana L Piña, G Michael Felker, Kirkwood F Adams, Robert M Califf, Mihai Gheorghiade. Circulation 2005
12
Hyponatremia and heart failure--pathophysiology and implications.
Domenic A Sica. Congest Heart Fail 2005
Domenic A Sica. Congest Heart Fail 2005
12
Hypertrophic growth of cultured neonatal rat heart cells mediated by vasopressin V(1A) receptor.
Y Nakamura, T Haneda, J Osaki, S Miyata, K Kikuchi. Eur J Pharmacol 2000
Y Nakamura, T Haneda, J Osaki, S Miyata, K Kikuchi. Eur J Pharmacol 2000
12
Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
Mihai Gheorghiade, Imran Niazi, John Ouyang, Frank Czerwiec, Jun-ichi Kambayashi, Manuela Zampino, Cesare Orlandi. Circulation 2003
Mihai Gheorghiade, Imran Niazi, John Ouyang, Frank Czerwiec, Jun-ichi Kambayashi, Manuela Zampino, Cesare Orlandi. Circulation 2003
12
Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Stephanie Neuhold, Martin Huelsmann, Guido Strunk, Brigitte Stoiser, Joachim Struck, Nils G Morgenthaler, Andreas Bergmann, Deddo Moertl, Rudolf Berger, Richard Pacher. J Am Coll Cardiol 2008
Stephanie Neuhold, Martin Huelsmann, Guido Strunk, Brigitte Stoiser, Joachim Struck, Nils G Morgenthaler, Andreas Bergmann, Deddo Moertl, Rudolf Berger, Richard Pacher. J Am Coll Cardiol 2008
12
Adverse consequences of high sympathetic nervous activity in the failing human heart.
D M Kaye, J Lefkovits, G L Jennings, P Bergin, A Broughton, M D Esler. J Am Coll Cardiol 1995
D M Kaye, J Lefkovits, G L Jennings, P Bergin, A Broughton, M D Esler. J Am Coll Cardiol 1995
12
Evidence for a vasopressin system in the rat heart.
H Hupf, D Grimm, G A Riegger, H Schunkert. Circ Res 1999
H Hupf, D Grimm, G A Riegger, H Schunkert. Circ Res 1999
12
Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signaling.
Xue Li, Tung O Chan, Valerie Myers, Ibrul Chowdhury, Xue-Qian Zhang, Jianliang Song, Jin Zhang, Jocelyn Andrel, Hajime Funakoshi, Jeffrey Robbins,[...]. Circulation 2011
Xue Li, Tung O Chan, Valerie Myers, Ibrul Chowdhury, Xue-Qian Zhang, Jianliang Song, Jin Zhang, Jocelyn Andrel, Hajime Funakoshi, Jeffrey Robbins,[...]. Circulation 2011
12
Angiotensin II induces catecholamine release by direct ganglionic excitation.
Andreas Dendorfer, Alexandra Thornagel, Walter Raasch, Olaf Grisk, Klaus Tempel, Peter Dominiak. Hypertension 2002
Andreas Dendorfer, Alexandra Thornagel, Walter Raasch, Olaf Grisk, Klaus Tempel, Peter Dominiak. Hypertension 2002
12
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
12
Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.
Cheryl L Holmes, Donald W Landry, John T Granton. Crit Care 2003
Cheryl L Holmes, Donald W Landry, John T Granton. Crit Care 2003
9
Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects.
L Bankir. Cardiovasc Res 2001
L Bankir. Cardiovasc Res 2001
9
Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist.
Alain Soupart, Peter Gross, Jean-Jacques Legros, Sándor Alföldi, Djillali Annane, Hassan M Heshmati, Guy Decaux. Clin J Am Soc Nephrol 2006
Alain Soupart, Peter Gross, Jean-Jacques Legros, Sándor Alföldi, Djillali Annane, Hassan M Heshmati, Guy Decaux. Clin J Am Soc Nephrol 2006
9
The syndrome of inappropriate secretion of antidiuretic hormone.
F C Bartter, W B Schwartz. Am J Med 1967
F C Bartter, W B Schwartz. Am J Med 1967
9
The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions.
Akito Tanoue, Shuji Ito, Kenji Honda, Sayuri Oshikawa, Yoko Kitagawa, Taka-Aki Koshimizu, Toyoki Mori, Gozoh Tsujimoto. J Clin Invest 2004
Akito Tanoue, Shuji Ito, Kenji Honda, Sayuri Oshikawa, Yoko Kitagawa, Taka-Aki Koshimizu, Toyoki Mori, Gozoh Tsujimoto. J Clin Invest 2004
9
Hyponatremia and vasopressin antagonism in congestive heart failure.
Siva Kumar, Sharon Rubin, Paul J Mather, David J Whellan. Clin Cardiol 2007
Siva Kumar, Sharon Rubin, Paul J Mather, David J Whellan. Clin Cardiol 2007
15
Phospholamban: a crucial regulator of cardiac contractility.
David H MacLennan, Evangelia G Kranias. Nat Rev Mol Cell Biol 2003
David H MacLennan, Evangelia G Kranias. Nat Rev Mol Cell Biol 2003
9
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.
Mihai Gheorghiade, Joseph S Rossi, William Cotts, David D Shin, Anne S Hellkamp, Ileana L Piña, Gregg C Fonarow, Teresa DeMarco, Daniel F Pauly, Joseph Rogers,[...]. Arch Intern Med 2007
Mihai Gheorghiade, Joseph S Rossi, William Cotts, David D Shin, Anne S Hellkamp, Ileana L Piña, Gregg C Fonarow, Teresa DeMarco, Daniel F Pauly, Joseph Rogers,[...]. Arch Intern Med 2007
9
Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin.
Nils G Morgenthaler, Joachim Struck, Christine Alonso, Andreas Bergmann. Clin Chem 2006
Nils G Morgenthaler, Joachim Struck, Christine Alonso, Andreas Bergmann. Clin Chem 2006
9
Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study.
Steven R Goldsmith, Uri Elkayam, W Herbert Haught, Abhijit Barve, Weizhong He. J Card Fail 2008
Steven R Goldsmith, Uri Elkayam, W Herbert Haught, Abhijit Barve, Weizhong He. J Card Fail 2008
9
Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure.
V L Szatalowicz, P E Arnold, C Chaimovitz, D Bichet, T Berl, R W Schrier. N Engl J Med 1981
V L Szatalowicz, P E Arnold, C Chaimovitz, D Bichet, T Berl, R W Schrier. N Engl J Med 1981
9
The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists.
M Thibonnier, P Coles, A Thibonnier, M Shoham. Annu Rev Pharmacol Toxicol 2001
M Thibonnier, P Coles, A Thibonnier, M Shoham. Annu Rev Pharmacol Toxicol 2001
9
Hyponatremia in patients with heart failure.
Leonardo De Luca, Liviu Klein, James E Udelson, Cesare Orlandi, Gennaro Sardella, Francesco Fedele, Mihai Gheorghiade. Am J Cardiol 2005
Leonardo De Luca, Liviu Klein, James E Udelson, Cesare Orlandi, Gennaro Sardella, Francesco Fedele, Mihai Gheorghiade. Am J Cardiol 2005
9
Neural control of renal function in edema-forming states.
G F DiBona, P J Herman, L L Sawin. Am J Physiol 1988
G F DiBona, P J Herman, L L Sawin. Am J Physiol 1988
9
Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia.
Jalal K Ghali, Michael J Koren, James R Taylor, Esther Brooks-Asplund, Kaisheng Fan, Walker A Long, Neila Smith. J Clin Endocrinol Metab 2006
Jalal K Ghali, Michael J Koren, James R Taylor, Esther Brooks-Asplund, Kaisheng Fan, Walker A Long, Neila Smith. J Clin Endocrinol Metab 2006
9
Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.
David Zeltser, Steven Rosansky, Hannes van Rensburg, Joseph G Verbalis, Neila Smith. Am J Nephrol 2007
David Zeltser, Steven Rosansky, Hannes van Rensburg, Joseph G Verbalis, Neila Smith. Am J Nephrol 2007
9
Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.
Douglas S Lee, Peter C Austin, Jean L Rouleau, Peter P Liu, David Naimark, Jack V Tu. JAMA 2003
Douglas S Lee, Peter C Austin, Jean L Rouleau, Peter P Liu, David Naimark, Jack V Tu. JAMA 2003
9
Upregulation of aquaporin-2 water channel expression in chronic heart failure rat.
D L Xu, P Y Martin, M Ohara, J St John, T Pattison, X Meng, K Morris, J K Kim, R W Schrier. J Clin Invest 1997
D L Xu, P Y Martin, M Ohara, J St John, T Pattison, X Meng, K Morris, J K Kim, R W Schrier. J Clin Invest 1997
9
Vasopressin increases cytosolic free [Ca2+] in the neonatal rat cardiomyocyte. Evidence for V1 subtype receptors.
Y J Xu, V Gopalakrishnan. Circ Res 1991
Y J Xu, V Gopalakrishnan. Circ Res 1991
9
Physiology and pathophysiology of renal aquaporins.
S Nielsen, T H Kwon, B M Christensen, D Promeneur, J Frøkiaer, D Marples. J Am Soc Nephrol 1999
S Nielsen, T H Kwon, B M Christensen, D Promeneur, J Frøkiaer, D Marples. J Am Soc Nephrol 1999
9
Clinical practice. The syndrome of inappropriate antidiuresis.
David H Ellison, Tomas Berl. N Engl J Med 2007
David H Ellison, Tomas Berl. N Engl J Med 2007
9
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.
Robert W Schrier, Peter Gross, Mihai Gheorghiade, Tomas Berl, Joseph G Verbalis, Frank S Czerwiec, Cesare Orlandi. N Engl J Med 2006
Robert W Schrier, Peter Gross, Mihai Gheorghiade, Tomas Berl, Joseph G Verbalis, Frank S Czerwiec, Cesare Orlandi. N Engl J Med 2006
9
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.
J N Cohn, T B Levine, M T Olivari, V Garberg, D Lura, G S Francis, A B Simon, T Rector. N Engl J Med 1984
J N Cohn, T B Levine, M T Olivari, V Garberg, D Lura, G S Francis, A B Simon, T Rector. N Engl J Med 1984
9
Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.
Arash Aghel, Kevin Shrestha, Wilfried Mullens, Allen Borowski, W H Wilson Tang. J Card Fail 2010
Arash Aghel, Kevin Shrestha, Wilfried Mullens, Allen Borowski, W H Wilson Tang. J Card Fail 2010
9
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.